Companies in the Consumer Packaged Goods and Food & Beverage industries rely on flavors and fragrances but have no scientific method to measure their effect on the consumer brain.
We provide a scientific, reproducible way to record tastes and smells, to digitally represent them, and see how they affect the consumer brain to speed, simplify and lower R&D, product development, manufacturing and QA costs.
Aromyx has designed a patent-protected, portable platform that puts all the human olfactory and taste receptors onto a disposable chip, in a stable and cost-effective way. We have designed chips and a portable chip reader that use the actual biochemical stack from the human nose and tongue. Customers buy the chip for $300 apiece. The chip is a one-use disposable. The chip costs $100 to manufacture and the path to drive that cost down significantly is well understood.
The Aromyx approach maintains both the sensitivity and specificity of the human nose and tongue. The array of biochemical signals produced by the chip is transduced into a digital aromagraph.
Our ability to accurately represent human olfactory experiences as an aromagraph will create broad new classes of business opportunities.
Our resilient, experienced team is our greatest strength.
Chris Hanson, CEO: IBM Research, Seagate, prior startups. Track record of large sales. Stanford University BA, MA.
Bill Harries, Ph.D., Chief Scientist: Center for Structures of Membrane Proteins, UCSF.
Luke Schneider, Ph.D., Board Member. SRI, inventor of this biosensor. Ph.D. from Princeton University.
Edward Costello, VP, Engineering: HP, Adobe, Palm, Lawrence Livermore.
Todd Cushman, VP, Sales: IBM, Zeneca Pharmaceuticals.
Processed food companies currently work with three crude levers – salt, sugar and fat – to maximize the appeal of their products. But imagine if food scientists had access to the 400 olfactory and taste receptors when they designed new products, and could leverage those practically unlimited combinations.
The Aromyx platform will modernize the enterprise in the Consumer Packaged Goods and Food & Beverage industries - from R&D and product development through manufacturing and quality assurance.
With Dr. Dharmendra Modha, started SyNAPSE cognitive computing program at IBM Research - efforts that have led to the IBM SyNAPSE brain-like neuromorphic chip, now being commercialized.
Led introduction of advanced security and high-availability technology into IBM server and software product lines that will revitalize products, leapfrog competition and result in billions of dollars of incremental revenue over the next five years.
- Glen Sato